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ABSTRACT
Human chromosomal fragile sites are specific loci
that are especially susceptible to DNA breakage fol-
lowing conditions of partial replication stress. They
often are found in genes involved in tumorigenesis
and map to over half of all known cancer-specific
recurrent translocation breakpoints. While their
molecular basis remains elusive, most fragile
DNAs contain AT-rich flexibility islands predicted
to form stable secondary structures. To understand
the mechanism of fragile site instability, we
examined the contribution of secondary structure
formation to breakage at FRA16B. Here, we show
that FRA16B forms an alternative DNA structure in
vitro. During replication in human cells, FRA16B
exhibited reduced replication efficiency and expan-
sions and deletions, depending on replication orien-
tation and distance from the origin. Furthermore, the
examination of a FRA16B replication fork template
demonstrated that the majority of the constructs
contained DNA polymerase paused within the
FRA16B sequence, and among the molecules,
which completed DNA synthesis, 81% of them
underwent fork reversal. These results strongly
suggest that the secondary-structure-forming
ability of FRA16B contributes to its fragility by
stalling DNA replication, and this mechanism may
be shared among other fragile DNAs.
INTRODUCTION
Fragile sites are speciﬁc chromosomal regions located
throughout the human genome that are especially suscep-
tible to DNA breakage. These regions are deﬁned
cytogenetically as gaps or breaks on metaphase chromo-
somes following conditions of partial replication stress.
Fragile sites are divided into two major classes based on
their frequency in the population and are subdivided
according to their mode of induction in cultured cells.
Rare fragile sites are found in <5% of the population
and are inherited in a Mendelian manner (1,2). The
majority of rare fragile sites can be induced under
folate-deﬁcient conditions and contain a microsatellite
(CGG)n repeat (3), whereas the rare, non-folate-sensitive
sites are comprised of an AT-rich minisatellite element (2).
In contrast, common fragile sites have been observed in all
individuals and are believed to represent a normal com-
ponent of chromosome structure (4). Most common
fragile sites are observed after exposure to low doses of
aphidicolin, an inhibitor of DNA polymerases a, d and e
(5,6). To date, over 80 common fragile sites are listed in
the Human Genome Database (GDB). Most have not yet
been investigated at the molecular level, but it is known
that regions of fragility can extend over megabases of
DNA with gaps or breaks occurring throughout (7).
Although a consensus sequence has not yet been identiﬁed
among common fragile sites, the DNAs examined thus far
contain frequent, AT-rich ﬂexibility islands capable of
forming secondary structures that are much more stable
compared to other regions of the genome (8), similar to
what has been reported for most rare sites.
Fragile sites are normally stable in cultured cells.
However, these sites are hotspots for sister chromatid
exchanges, deletions and rearrangements after induction
with replication inhibitors (9,10). Moreover, many fragile
sites are frequently associated with sites of chromosomal
breakage in tumors (11,12). While the exact mechanism of
fragile site expression remains elusive, replication timing
experiments have shown that all fragile sites studied to
date, including FRAXA (13), FRA3B (14), FRA7H
(15), FRA10B (16), FRA16B (16), FRA1H (17) and
FRA2G (17) exhibit delayed replication. The delay is
further exacerbated by the addition of replication inhibi-
tors, with some fragile site alleles remaining unreplicated
in late G2 phase (14,15). Although it is not entirely clear
how delayed replication at fragile sites results in chromo-
some breakage, evidence suggests that DNA sequences
with the potential to form stable secondary structures
can present signiﬁcant diﬃculties during replication,
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are visible as gaps and breaks during metaphase (18). The
(CGG)n repeat within rare, folate-sensitive sites has been
shown to form hairpin (19) and quadruplex structures (20)
that present a signiﬁcant block to replication both in vitro
and in vivo (21,22), whereas a polymorphic AT-rich
sequence with the ability of forming a cruciform within
common fragile site FRA16D blocked replication in yeast,
resulting in increased chromosome breakage (23).
Several studies have demonstrated a critical role for the
Ataxia-Telangiectasia and Rad3-Related (ATR)-depen-
dent DNA damage checkpoint pathway in the mainte-
nance of fragile sites. Although their direct roles remain
unclear, proteins including the S-phase and G2/M check-
point kinase ATR (18), as well as its downstream targets
BRCA1 (24) and CHK1 (25), are required for fragile site
stability, as their deﬁciencies result in signiﬁcantly
increased fragile site breakage. ATR is a major component
of the checkpoint pathway where it functions by sensing
and responding to DNA damage, including stalled and
collapsed replication forks (26,27). Based on this
evidence, it is hypothesized that ATR maintains fragile
site stability by sensing and binding to single-stranded
DNA resulting from stalled replication forks at sites of
secondary structure formation (18), and that a deﬁciency
or defect in ATR can prevent repair, leading to increased
fragile site expression. Supporting this hypothesis, cells
from patients with Seckel syndrome, who have low
levels of ATR protein, show increased instability at
fragile sites compared to normal cells following replication
stress (28). This diﬀerence in instability suggests that the
low level of ATR present in Seckel syndrome patients is
not suﬃcient to respond to replication stress, consistent
with the hypothesis that the breaks observed on
metaphase chromosomes are unreplicated fragile sites
that escape the ATR checkpoint (18).
To further understand the mechanism of breakage at
human chromosomal fragile sites, we have investigated
the cause of instability at fragile site FRA16B (29).
Spontaneous FRA16B expression has been observed
among individuals and can be induced by chemicals that
bind AT-rich DNA, such as distamycin A (30) or berenil
(31). Studies of FRA16B, located at 16q22.1, have shown
that it spans the same genomic region as the common
fragile site FRA16C and is also apparent following treat-
ment with aphidicolin (8). After induction, the
heterozygote frequency of FRA16B is about 5% in pop-
ulations of European descent, representing the most
frequently expressed rare fragile site (32). Positional
cloning has revealed that FRA16B-expressing chromo-
somes may contain up to 2000 copies of a 33-bp
AT-rich minisatellite repeat (ATATATTATATATTATA
TCTAATAATATATC/ATA), whereas normal chromo-
somes consist of only 7–12 copies of the repetitive
element (33). Competitive nucleosome reconstitution
assays demonstrate that, in the presence of distamycin
A, FRA16B DNA displays nucleosome exclusion (29,34)
that increases in proportion to the number of repeats
(29,34). These results, along with similar studies on
various other fragile sites (35–37), suggest a common
feature for the chromatin structure surrounding fragile
DNAs, which may play an important role in their expres-
sion. Therefore, FRA16B serves as a model for the exam-
ination of fragile sites, since it exhibits characteristics of
both common and rare fragile sites, and has been mapped
to cancer-speciﬁc rearrangements (12).
CGG repeats underlying the basis of fragility at rare,
folate-sensitive fragile sites have been shown to form a
secondary structure in vitro (38), but there is no physical
evidence of alternative DNA structures for AT-rich fragile
DNA, which comprises the majority of fragile sites.
Therefore, it is important to determine whether these
sequences are capable of forming secondary structures.
It is also critical to investigate the contribution of second-
ary structure formation on chromosome instability.
Recently, Ragland et al. (39) demonstrated the ability of
common fragile DNAs to induce chromosome instability
at ectopic sites in HCT116 cells, although the relationship
between common fragile site instability and secondary
structure was not investigated. In addition, the role of
secondary structure formation in chromosome instability
has been determined in yeast (23) but has not yet been
investigated in human cells.
In this study, the ability of FRA16B to form a second-
ary structure in vitro was demonstrated by a reduction of
electrophoretic mobility in polyacrylamide gels and visu-
alization of short, branched structures by electron micros-
copy (EM). It was also determined that both replication
orientation and distance from FRA16B to the origin aﬀect
FRA16B replication eﬃciency and instability in human
cells. Furthermore, examination of FRA16B replication
fork templates by EM revealed a tendency for FRA16B
DNA to promote spontaneous fork reversal and an even
greater occurrence of polymerase pausing at speciﬁc sites
within the FRA16B region, which was conﬁrmed by DNA
sequencing gels. Overall, these results strongly suggest that
the secondary structure-forming ability of FRA16B con-
tributes to its fragility by stalling DNA replication, and
this mechanism may be shared among other fragile DNAs.
MATERIALS AND METHODS
Plasmids
FRA16B-containing plasmids were created using genomic
DNA from an individual expressing the FRA16B chromo-
some. A 921-bp fragment of FRA16B consisting of 14
perfect copies of the 33-bp AT-rich minisatellite repeat
and some imperfect repeats with AT-rich ﬂanking
sequences was cloned as described in (34) to generate
pFRA16B18.
To construct SV40 replication templates, the FRA16B
fragment described above and the SV40 origin of replica-
tion (ori) (40) were cloned into pGEM3zf(+) (Promega).
The FRA16B sequence was inserted at one of four diﬀer-
ent distances relative to the ori, and in one of two possible
replication orientations. This generated eight constructs
with the FRA16B sequence located 30, 300, 400 or
700bp from the origin of replication in two diﬀerent rep-
lication orientations (Figure 2A). A plasmid containing
the SV40 ori only with no FRA16B sequence
(pGEM-SV40ori) served as a control.
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plimentary oligonucleotides (50-AGCTTGCATGCCTGC
AGGCTGAGGA-30 and 50-CCTCAGCCTGCAGGCAT
GCA-30) containing a site for the nicking endonuclease
Nb.BbvCI (New England Biolabs) were annealed and
cloned into the EcoRI and HindIII sites of pFRA16B18
adjacent to the 921-bp FRA16B fragment to create
pFRA16B37 (Supplementary Figure S1). The FRA16B
DNA-containing sequence of pFRA16B37, and the
Nb.BbvCI recognition site are also indicated in
Supplementary Figure S1. The construction of these
plasmids will allow us to examine DNA polymerase
stalling, and replication fork regression of a 487-bp
fragment of FRA16B DNA (see below).
Reduplexing assay
Reduplexing reactions were performed as previously
described in (38,41,42). Brieﬂy, the FRA16B fragment
from pFRA16B18 was obtained by restriction enzyme
digest using EcoRI and HindIII (New England Biolabs),
and gel-puriﬁed. The FRA16B fragment was then
dephosphorylated at the 50 end with calf intestinal
alkaline phosphatase (New England Biolabs) and
end-labeled with [a-
32P] ATP (PerkinElmer) using T4
kinase (New England Biolabs). End-labeled DNA (1ng)
was added to solutions of 500ml containing 1, 0.58, 0.3 or
0.1M NaCl in TE buﬀer and incubated at 95˚ C for 5min.
The samples were cooled to room temperature, and the
DNA was ethanol-precipitated in the presence of glycogen
(Roche). The DNA pellets were then air-dried and
resuspended in TE buﬀer. As a control, pGEM3zf(+)
was digested with EcoRI and Eco109I (New England
Biolabs) to generate an 892-bp fragment, and was sub-
jected to the same conditions as FRA16B. DNA samples
were electrophoresed in a 4% polyacrylamide gel cast in
TBE at 50V for 18h at room temperature. The gel was
dried and visualized by phosphorimaging (GE
HealthCare).
EM
Reduplexed DNAs or replication fork template reaction
mixtures were directly mounted onto glow-charged
carbon-coated copper EM grids followed by washing in
a water/ethanol gradient and rotary shadowcasting with
tungsten, as described previously (43). DNAs were
visualized on a Philips transmission electron microscope
400. Measurements of the DNA lengths were determined
using Image J software (NIH).
Replication eﬃciency
The human embryonic kidney HEK293T cells were grown
in Dulbecco’s modiﬁed Eagle’s media (Gibco) containing
10% fetal bovine serum (HyClone) and 1% penicillin
streptomycin (Gibco) on 100-mm-diameter plates. The
cells were 50% conﬂuent when co-transfected with 2.5mg
of pGEM-SV40ori and 2.5mg of each FRA16B/SV40
plasmid using the CaPO4 method. The cells were
allowed to grow for 16h following transfection before
replacing the media. Low-molecular-weight DNA was
extracted by the Hirt’s lysis method (44) 48h after
transfection. The SV40 viral DNAs were further puriﬁed
by incubation with proteinase K, phenol/chloroform
extraction and alcohol precipitation. To determine repli-
cation eﬃciency of the constructs (Figure 2B),
SV40-replicated DNAs were digested with HindIII and
NdeI (New England Biolabs) to linearize the plasmids,
and with DpnI (New England Biolabs) to remove
unreplicated parental templates. For clone 46, EcoRI
was used in place of HindIII. Southern blot analysis was
then used to identify replicated DNAs using an [a-
32P]
dCTP-labeled probe hybridizing to nucleotide numbers
1725–2132 of pGEM3zf(+), which is present in all nine
constructs. Replication eﬃciency was determined by the
ratio of replicated FRA16B DNA to the control
(pGEM-SV40ori) using ImageQuant version 5.2 to
measure the intensity of each band. Student’s t-test was
performed to determine statistically signiﬁcant diﬀerences
between clones.
Mutation assay
To investigate instability associated with FRA16B, a
modiﬁed version of the stability of trinucleotide repeat
by individual product (STRIP) assay (45) was used to
examine individual products following replication in
human cells. Essentially, products of replication from
transfected HEK293T cells were digested with DpnI to
eliminate any unreplicated parental templates and trans-
formed into SURE-2 cells (Stratagene) (Figure 2B).
Approximately 60 single colonies from each clone were
picked at random, and the DNAs were isolated and
digested with appropriate restriction enzymes to release
the FRA16B insert. Samples were then run on 1.5%
agarose gels and scored for insertion or deletion events,
characterized by slower or faster migrating bands, respec-
tively, compared to unreplicated DNA. As an additional
control to measure the background instability in
Escherichia coli, DNAs that were not transfected into
HEK293T cells were directly transformed into SURE-2
cells, and scored for instability events. Fisher’s exact test
was used to determine the statistical signiﬁcance of insta-
bility resulting from replication in HEK293T cells
compared to the background instability in E. coli,a s
well as diﬀerences between FRA16B-containing con-
structs compared to the control.
Analysis of FRA16B synthesis by the Klenow fragment
of DNA polymerase I
A DNA template (pFRA16B37) was synthesized which
mimics a replication fork that has progressed through
clone 17 FRA16B sequence. The plasmid was digested
with Nb.BbvCI to generate a nick directly in front of
the FRA16B fragment that does not contain any
cytosine bases for a length of 487bp (Supplementary
Figure S1). The nicked DNA was then incubated with
5U of the Klenow fragment (exo-) of DNA polymerase
I (New England Biolabs) in a reaction mixture containing
7.5mM Tris, pH 7.5, 5mM MgCl2 and 5mM DTT with
2.5mM each dATP, dTTP and dGTP nucleotides. The
absence of cytosine caused DNA synthesis to stop at the
end of the repetitive tract when the ﬁrst guanine was
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single-strand tail by strand displacement. This resulted
in a duplex circle with a single-strand tail where the tail
represents the lagging strand, one arm of the circle is the
leading strand and the other arm serves as the template
(Figure 3A). To examine DNA synthesis on the lagging
strand, a 50-fold molar excess of the complementary
oligonucleotide (50-ATATAATA-TATTATTATATCTA
ATA-30) was annealed to the lagging strand at the 30
end for 30min at 37 ˚ C in a buﬀer containing 7.5mM
Tris, pH 7.5, 5mM MgCl2 and 5mM DTT with 2.5mM
each dATP, dTTP and dCTP nucleotides, and further
incubation with 5U of Klenow fragment (exo-) for
30min at 37 ˚ C. The reaction mixture was puriﬁed and
examined by EM for DNA synthesis. To serve as a
control, a plasmid containing non-fragile site DNA
(pGLGAP) was kindly provided by Dr. Jack Griﬃth
(UNC-CH) and constructed using the same conditions
as the FRA16B replication fork template (46).
To detect the pause sites on the lagging strand, the same
oligonucleotide was radiolabeled and annealed to the
lagging strand in the same reaction conditions as described
above. DNA synthesis was carried out using 0.5, 5 and
15U of Klenow fragment (exo-). The reaction mixtures
were puriﬁed, resuspended in formamide/dye solution,
electrophoresed through 12% polyacrylamide-7M urea
gels, and examined by phosphorimager analysis.
To locate the position of the replication fork for
detecting fork regression, the reaction mixtures were
linearized with AhdI or XmnI (New England Biolabs),
to produce asymmetrical arms for measuring the
distance from the fork junction to the DNA ends, and
the samples were examined by EM.
RESULTS
Secondary structure formation of FRA16B DNA
Since there has been no physical evidence of alternative
DNA structures formed for AT-rich fragile DNAs, we
investigated secondary structure formation by subjecting
a 921-bp fragment of FRA16B to reduplexing in the
presence of various concentrations of NaCl to allow
re-annealing of the single strands following denaturation.
Separation by polyacrylamide gel electrophoresis (PAGE)
showed that the reduplexed FRA16B fragment gave rise
to two slower-migrating products over a range of NaCl
concentrations (Figure 1A). These products were not
present in the untreated FRA16B sample or the
reduplexed pGEM3zf(+) control, suggesting the forma-
tion of a secondary structure during reduplexing of
FRA16B DNA. Furthermore, when FRA16B was
denatured and only one strand of the duplex was labeled
with
32P, the labeled strand corresponded uniquely to one
of the bands with reduced electrophoretic mobility,
demonstrating that each reduplexed band is produced
from one of the two strands of FRA16B (Supplementary
Figure S2). The examination of these molecules by EM
conﬁrmed that FRA16B folded into branched duplexes
following denaturation and re-annealing (Figure 1B).
These structures were not observed in the untreated
FRA16B or reduplexed pGEM3zf(+) samples. The
lengths of 100 DNA molecules from each sample were
measured, and the comparison revealed that the
reduplexed FRA16B molecules were shorter than the
untreated FRA16B DNAs, indicating the presence of
slipped-out regions participating in the formation of sec-
ondary structure. These data are the ﬁrst to demonstrate
that FRA16B is indeed able to form an alternative DNA
structure in vitro.
Reduced replication eﬃciency and increased instability
of FRA16B in human cells
To analyze FRA16B replication in human cells, an SV40
system was used to evaluate replication eﬃciency and
instability of FRA16B-containing constructs. Since
several studies have shown that the ability of a sequence
to inhibit replication depends on cis-acting factors,
including replication orientation and distance relative to
the origin (22,23,45,47–49), the 921-bp FRA16B insert
was placed at varying distances from the SV40 ori and
in one of two replication orientations to generate eight
constructs containing FRA16B (Figure 2A). A control
plasmid that does not contain FRA16B DNA was also
constructed. An equal amount of the control plasmid
and each FRA16B-containing plasmid was co-transfected
into HEK293T cells (Figure 2B). Following SV40 replica-
tion, the DNAs were linearized and digested with DpnI to
remove unreplicated parental templates. Replication eﬃ-
ciency was determined on Southern blots as the ratio of
completely replicated FRA16B DNA to the control
(Figure 2C). Clone 17 exhibited a statistically signiﬁcant
reduction in replication eﬃciency compared to clone 15
(P=0.045), indicating that orientation aﬀects replication
eﬃciency. The eﬃciency of replication for clone 17 was
also reduced when compared to clone 34 (P=0.073),
clone 10 (P=0.003), clone 12 (P=0.005) and clone 46
(P=0.083). Our results demonstrate that both the repli-
cation orientation and distance from the origin aﬀect
FRA16B replication.
Next, a mutation assay was performed to determine if
instability events were occurring within FRA16B during
replication in HEK293T cells. Individual replication
products were examined using a modiﬁed version of the
STRIP assay (45), originally designed to determine the
role of mammalian replication on the stability of triplet
repeats. Replication products from transfected HEK293T
cells were digested with DpnI and transformed into E. coli
(Figure 2B). Only DpnI-resistant material yielded
colonies, from which DNAs were isolated and digested
with restriction enzymes to release the FRA16B insert.
FRA16B inserts were resolved on agarose gels and
scored for insertions or deletions (Figure 2D). Due to
the resolution of agarose gels, mutations with only large
size changes ( 50bp) were detected. The mutation fre-
quency for each construct is shown in Figure 2E.
Interestingly, clone 17, which displayed the greatest reduc-
tion in replication eﬃciency, also demonstrated a statisti-
cally signiﬁcant increase in instability events compared to
the background instability in E. coli (P=0.022) and the
control construct without FRA16B DNA in HEK293T
2868 Nucleic Acids Research, 2010,Vol.38, No. 9cells (P=0.016). Replication of clone 17 in HEK293T
cells resulted in the highest mutation rate (9%) among
all of the FRA16B constructs, with four deletions
(ranging from 99 to 378bp) and one expansion (33bp)
(Figure 2F), which were conﬁrmed by DNA sequencing.
The 378-bp deletion in mutant 17-4 and the 165-bp
deletion in mutant 17-18 begin, respectively, at nt 58 and
nt 207 of the lagging strand template of the FRA16B
sequence, located at the ﬁrst Okazaki initiation zone
(OIZ). The 99-bp deletion in mutant 17-8 and the
224-bp deletion in mutant 17-34 begin, respectively, at
nt 364 and nt 406 of the lagging strand template of
the FRA16B sequence, located at the second OIZ.
The 33-bp insertion in mutant 17-48 begins at nt 325,
and is one perfect copy of the 33-bp FRA16B repeat.
Mapping of the mutation sites to the most energetically
favorable predicted DNA secondary structures of the
lagging strand template of the FRA16B sequence, as
determined by Mfold (50) suggests that the deleted
regions may correspond to sites of extensive secondary
structure formation, including multiple hairpins
(Supplementary Figure S3).
DNA polymerase stalling at FRA16B during DNA
synthesis
Evidence has shown that the formation of secondary
structures by CGG repeats can block replication within
Figure 1. Secondary structure formation of FRA16B DNA following denaturation and re-annealing (reduplexing) reaction. (A) Gel electrophoresis
analysis of re-annealed FRA16B DNA. DNA fragments of FRA16B (right) and pGEM3zf(+) (left) were subjected to reduplexing in increasing salt
concentrations (0.1–1M) and analyzed by native 4% PAGE. C, untreated samples; M, molecular weight marker. (B) Visualization of reduplexed
FRA16B DNA by EM. After reduplexing reactions, samples were directly mounted onto carbon-coated copper EM grids and rotary shadowcasted
with tungsten. Images are shown in reverse contrast. The total lengths of 100 molecules from each sample were measured using Image J software
(lower right).
Nucleic Acids Research,2010, Vol.38, No. 9 2869Figure 2. Analysis of FRA16B replication eﬃciency and instability in human cells using an SV40 replication system. (A) Diagram of replication
constructs used for replication eﬃciency and instability assays. The bidirectional SV40 ori (open circles) was cloned into pGEM3zf(+) to generate
pGEM-SV40ori, used as a control. The 921-bp FRA16B fragment (shaded box) was inserted 30, 300, 400 or 700bp from the SV40 ori, and in one of
two replication orientations (represented by arrows). (B) Schematic of strategy used to determine the replication eﬃciency of FRA16B constructs and
instability events following replication in HEK293T cells. To determine replication eﬃciency, equal amounts of pGEM-SV40ori and each
FRA16B-containing construct were co-transfected into HEK293T cells. After replication for 48h, SV40 DNAs were extracted, puriﬁed and
digested with DpnI to remove any unreplicated templates. Replicated molecules were then subjected to Southern blot analysis. To examine
FRA16B-associated instability, each FRA16B-containing construct was transfected and replicated in HEK293T cells. SV40 DNA was extracted,
puriﬁed and digested with DpnI to remove any unreplicated templates. These DNAs were transformed into E. coli, isolated, and digested with
restriction enzymes to release the FRA16B insert. Replication products were analyzed on 1.5% agarose gels to score insertions and deletions. As a
control, replication constructs were directly transformed into E. coli, without replication in human cells, to account for background instability in
E. coli.( C) Replication eﬃciency of FRA16B constructs in HEK293T cells. The replication eﬃciency of each FRA16B-containing construct was
determined by the ratio of replicated FRA16B DNA to the control (pGEM-SV40ori). Results are shown as the mean±SD from six individual
experiments. (D) Identiﬁcation of mutation events of replication in HEK293T cells using gel electrophoresis. A representative agarose gel shows
(continued)
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tion forks have a high tendency to regress while moving
through diﬃcult-to-replicate DNA sequences (30,51). To
further investigate these possible mechanisms of instabil-
ity, we constructed replication fork templates
pFRA16B37, a plasmid containing FRA16B that
mimicked clone 17, and pGLGAP, a control containing
non-fragile site DNA (Figure 3A). Following DNA syn-
thesis by Klenow fragment, circular pFRA16B37 and
pGLGAP molecules were examined by EM (Figure 3C,
top panels). We found that 73% of pGLGAP molecules
had double-stranded tails, indicating that they underwent
completed DNA synthesis, whereas 24% did not (Figure
3B). In contrast, only 10% of pFRA16B37 molecules
completed DNA synthesis and had double-stranded
tails. Moreover, a majority of pFRA16B37 molecules
(73%) had no detectable DNA synthesis (i.e. no
double-stranded tails) and contained polymerase ‘stuck’
to the DNA, even after phenol/chloroform extraction
(Figure 3C). To locate the FRA16B sequence, the
samples were further linearized with restriction enzymes
to generate asymmetric arms (Figure 3C, bottom right
panel). We observed that most (68%) of the
polymerase-bound molecules had polymerases located
within the FRA16B sequence, which is located at 33–
50% of the total DNA length from the nearest end, sug-
gesting that the majority of the polymerase was stalled at
the FRA16B region and was not able to proceed with
DNA synthesis (Figure 3D).
Because of the high occurrence of polymerase stalling
within FRA16B, synthesis products were analyzed on
DNA sequencing gels to examine the progression of the
polymerase during DNA synthesis of the lagging strand,
and to locate polymerase pause sites. We found that
FRA16B DNA displayed strong pause sites, speciﬁcally
at nucleotides 8, 9 and 11 of the newly synthesized
strand, and was not able to complete the synthesis, while
the control DNA exhibited unperturbed synthesis and
generated its full-length product of 400nt (Figure 3E).
These results are in agreement with our observation of
Figure 2. Continued.
individual HEK293T cell replication products from clone 17. Replication products (#4 and #8) exhibit large base pair deletions, as demonstrated by
faster migrating products (asterisks) compared to unreplicated DNA (designated as C). M, molecular weight marker. (E) Mutation analysis of
FRA16B constructs with diﬀerent replication orientations and distances from the SV40 ori. After replication in HEK293T cells, puriﬁed SV40 DNA
was digested to eliminate any unreplicated parental templates and transformed into E. coli. Approximately 60 single colonies from each clone were
picked at random, and the DNAs were isolated and digested with restriction enzymes to release the FRA16B insert. Samples were then
electrophoresed in agarose gels to compare to unreplicated DNA and scored for insertion or deletion events (black bars). As a control, DNAs
that were not transfected into HEK293T cells were also transformed into E. coli and scored for background instability in E. coli (white bars). The
fractions within each bar show the number of molecules mutated over the total number of molecules examined. FRA16B instability is displayed as a
percentage, and the schematic drawings above each data set show the relative location of the SV40 ori (open circles) and the replication orientation
(arrows) of the FRA16B sequence (black boxes). Clone 17 demonstrates a statistically signiﬁcant increase in instability events in HEK293T cells
relative to background instability (*P=0.022), and to the control (**P=0.016). (F) Analysis of mutations generated by replication of clone 17 with
SV40 ori in HEK293T cells. For the ﬁve mutants, the type of mutation, size of the mutation (in bp) and distance (in bp) from SV40 ori are reported
in the table.
Nucleic Acids Research,2010, Vol.38, No. 9 2871Figure 3. FRA16B DNA synthesis by Klenow fragment of E. coli DNA polymerase I. (A) Construction of replication fork templates to examine
fork regression. Plasmids containing FRA16B clone 17 fragment (pFRA16B37, Supplementary Figure S1) or a G-less cassette (pGLGAP) were
constructed, nicked with Nb.BbvCI at a site immediately upstream of the inserts (bold), and incubated with Klenow fragment to generate a
single-strand tail by strand displacement. The single-strand tail was converted into a double-strand tail by annealing a complimentary oligonucleotide
at the 30 end of the displaced strand and further incubation with Klenow fragment. To map the location of the double-strand tail, plasmids were
linearized so measurements of the two asymmetrical tails could be obtained to determine the amount of fork regression. (B) Classiﬁcation of circular
DNA molecules after Klenow fragment reaction by EM. After the second Klenow reaction to create a double-strand tail, reaction mixtures were
directly mounted onto carbon-coated copper EM grids and rotary shadowcasted with tungsten. At least 100 molecules from each sample were
examined to determine the percentage of molecules with tails, protein-bound, or without a tail. (C) Visualization of circular and linear pGLGAP and
pFRA16B37 DNAs after synthesis reaction with Klenow fragment. Representative images were montaged and are shown in reverse contrast.
(D) Location of bound polymerases within FRA16B replication fork templates. The location of the polymerase as a percentage of the total
length is plotted as a histogram for all FRA16B molecules that displayed bound polymerase and did not contain a double-stranded tail. The
FRA16B fragment is located at 33–50% of the total length from the nearest end. (E) Analysis of DNA polymerase pause sites during lagging strand
DNA synthesis. Radiolabeled oligomers were annealed to the displaced lagging strand of pGLGAP (lanes 1–3) and pFRA16B37 (lanes 5–7)
replication fork templates, and synthesis was carried out with 0.5U (lanes 1 and 5), 5U (lanes 2 and 6) or 15U (lanes 3 and 7) of Klenow
fragment. Lane 4 (C) contained the radiolabeled 25-nt oligonucleotide only. The ﬁrst 12nt of the newly synthesized complimentary strand
are indicated, and the pause sites are boxed. (F) Detection of FRA16B replication fork regression. Circular replication fork molecules were
linearized with AhdI to produce asymmetrical arms. The location of the double-strand tail was deﬁned as the percentage of total DNA length
from the nearest end.
2872 Nucleic Acids Research, 2010,Vol.38, No. 9polymerase-trapped molecules by EM, and suggest that
FRA16B DNA inhibits the progression of DNA
polymerase, possibly due to its ability to form secondary
structure.
Next, we analyzed fork regression with the FRA16B
molecules containing double-stranded tails. These mole-
cules were a small fraction (10%) of the total population
but could represent a fully regressed, non-regressed, or
partially regressed replication fork, depending on the
location of the double-stranded tails. The location of the
double-strand tail was indicated as the percentage of total
DNA length from the nearest end. For the FRA16B
template, if no regression occurred, the tail would be
located at 46% of the total length, whereas under
complete regression, templates would have the tail
located at 34% of the total length (Figure 3F). FRA16B
forks were considered to have regressed when the
double-stranded tails were located  40% of the total
length, which is halfway between non- and fully regressed.
Out of the 32 molecules analyzed, 26 (81%) underwent
fork regression, whereas six (19%) did not display fork
reversal. As a control, pGLGAP templates were
examined (n=81), and our results were consistent with
previous studies, demonstrating that  10–20% of
random, nonrepetitive DNAs undergo some degree of
spontaneous fork regression (46,52). These results show
that fragile site-containing replication forks have a
greater tendency to undergo fork reversal than non-fragile
site sequences.
We also found that even in non-regressed molecules
which underwent DNA synthesis, the average length of
FRA16B tails was only 21% of the full length, whereas
the average length of the control pGLGAP template tails
was 85% of the total length. These results suggest that the
shorter double-stranded tails generated by DNA synthesis
of FRA16B templates could result from bypass of a
slipped-out secondary structure formed on the lagging
strand template, leading to the generation of deletion
mutations, as we observed following FRA16B replication
in human cells. Together, these data suggest that
polymerase pausing, fork reversal, or polymerase
skipping at FRA16B could contribute to its instability.
DISCUSSION
To gain a better understanding of the mechanism of insta-
bility at chromosomal fragile sites, we examined the ability
of FRA16B to form a secondary structure in vitro and
evaluated the eﬀects of cis-acting factors on replication
of FRA16B DNA. Previously, it has been shown that
the CGG repeat, which underlies the basis of fragility
at rare, folate-sensitive fragile sites, is able to form a
stable secondary structure (19,20) that presents signiﬁcant
diﬃculties during replication (21,22). However, the ability
of an AT-rich fragile DNA to form a secondary structure
in vitro has not been demonstrated until now. Our data
show that FRA16B DNA forms an alternative structure
Figure 3. Continued.
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edge, this is the ﬁrst experimental evidence of an AT-rich
fragile DNA, which represents the majority of fragile sites,
forming a secondary structure in vitro. This observation
supports the concept that formation of highly stable
secondary structures could be a general mechanism that
contributes to fragile site breakage during DNA replica-
tion (18).
Since prior reports have indicated potential problems
with replication due to DNA secondary structures,
FRA16B replication in human cells was also examined.
We determined that, similar to previous results, cis-
acting factors including replication orientation and
distance from the origin do play a role in both replication
eﬃciency and instability of FRA16B-containing con-
structs in human cells. Numerous studies have suggested
that replication orientation, which determines leading and
lagging strand synthesis, has a signiﬁcant eﬀect on repli-
cation eﬃciency as well as both the type and frequency of
mutations (45,47–49). In general, an increase in the
number of mutations is observed when the more
structure-prone strand serves as the lagging strand
template. Thus, when the strand with the most potential
to form a stable secondary structure serves as the lagging
strand template, the DNA is more likely to fold into an
alternative structure within the regions that maintain
single-strandedness. Consistent with previous studies, we
found that orientation greatly aﬀects replication eﬃciency
in that clone 17 possessed a markedly lower eﬃciency than
clone 15, yet they diﬀered only in orientation. Clone 17
also displayed a higher frequency of mutations than clone
15 during replication in HEK293T cells. Although both
strands of FRA16B are able to form secondary structure,
as shown in Figure 1A, we found that there are clearly
diﬀerent structures being formed by each strand, based
upon their diﬀerent electrophoretic mobilities
(Supplementary Figure S2). The more rapid mobility of
the template strand in Supplementary Figure S2 supports
the idea that the lagging strand template in the unstable
orientation forms a more stable secondary structure than
the template strand in the stable orientation. These data
prompt us to propose that one structure may be more
‘deleterious’ to DNA replication than the other, thus
leading to an orientation eﬀect similar to what has been
observed when only one strand forms a stable alternative
structure. Although signiﬁcant diﬀerences were not
observed among the other sets of FRA16B constructs
(clones 31 and 34, clones 10 and 12 and clones 46 and
39), this could be due to the fact that in these constructs,
FRA16B DNA is at least 300bp away from the origin,
and orientation may only be a factor when the fragile site
is in close proximity to the origin. This is likely due to the
location of secondary structures within the Okazaki initi-
ation zone (OIZ), a region of  300nt that remains single
stranded. Placing the beginning of the 921bp FRA16B
DNA fragment 30bp from the SV40 ori, as was the case
for clones 15 and 17, would have FRA16B occupy the ﬁrst
OIZ, promoting the formation of an alternative DNA
structure. The other sets of FRA16B constructs have the
start of the FRA16B sequence located at the second or
the third OIZs. The placement of the beginning of the
FRA16B sequence in diﬀerent OIZs might aﬀect the
ability of FRA16B to form stable secondary structure,
due to the binding cooperativity of RPA protein (53).
The binding of RPA in the ﬁrst OIZ could propagate to
the second and third OIZs, and might prevent the forma-
tion of alternative structure by FRA16B, when FRA16B
sequence begins at the second and third OIZs. In contrast,
clone 17 locates in the ﬁrst OIZ, and its ability to form
alternative structure might trump the initial binding of
RPA protein. Consequently, both the orientation and
location of FRA16B within clone 17 played a signiﬁcant
role in reducing DNA replication eﬃciency and increasing
the number of mutations. Furthermore, the large base pair
deletions that occurred within FRA16B during replication
in human cells recapitulate what has been observed at
fragile sites in numerous tumors in vivo. The most ener-
getically favorable predicted secondary structure of the
lagging strand template of clone 17 (50) suggested that
the deleted regions may occur at sites of extensive second-
ary structure formation, including multiple hairpins
(Supplementary Figure S3), further supporting a potential
role for secondary structure at sites of DNA breakage
within fragile sites. Possible explanations for the increase
in mutation frequency and decrease in replication eﬃ-
ciency observed for the FRA16B constructs in the SV40
replication system are: (i) the formation of a secondary
structure close to the origin hinders loading of the repli-
cation machinery, leading to decreased replication eﬃ-
ciency, and/or (ii) secondary structure formation within
single-stranded DNA regions during replication causes
insertions via replication restart, or deletions following
bypass of the structure or cleavage of a regressed fork-
all of which are consequences of replication fork stalling.
Since clone 17, which is located 30bp from the SV40 ori,
exhibited a statistically signiﬁcant decrease in replication
eﬃciency, it is conceivable that inhibition of origin ﬁring is
contributing to what is observed. In contrast, clones 31,
34, 10, 12, 46 and 39, which all place FRA16B at least
300bp from the origin of replication, do not demonstrate
a signiﬁcant reduction in replication eﬃciency, and this
suggests replication may initiate unperturbed. However,
the increased frequency of instability events for clone 17
following replication in HEK293T cells supports replica-
tion fork stalling, which is a consequence of DNA elon-
gation. Analysis of all ﬁve mutants derived from clone 17
demonstrates that sites of deletions and expansions
occurred as much as  400bp from the origin of replica-
tion (Figure 2F), suggesting that DNA replication was
initiated but paused at a site located at a greater
distance from the origin. A similar study, which
examined the ability of the CCTG repeat to cause muta-
tions, reports comparable results, demonstrating that
when the repeat is located  25bp from the SV40 ori,
an increase in expansions and deletions is observed,
also suggesting replication fork stalling during DNA
synthesis (47).
To dissect the mechanism for the generation of such
mutations within FRA16B during replication, we con-
structed a replication fork template mimicking clone 17
with FRA16B DNA  30bp from the initial replication
fork and the same replication orientation as clone 17.
2874 Nucleic Acids Research, 2010,Vol.38, No. 9Visualization of FRA16B replication fork molecules by
EM showed that the majority of DNAs contained
polymerases ‘stuck’ at the FRA16B region, and analysis
of the lagging strand synthesis conﬁrmed that the
polymerase had stalled at speciﬁc sites within the
FRA16B tract. As these polymerase-trapped molecules
were not observed with the non-fragile DNA control
template (Figure 3B), we suggest that the formation of
secondary structure by FRA16B DNA may be responsible
for polymerase pausing. Further, examination of replica-
tion fork templates containing either the telomeric or
CTG repeats, which have been shown to form hairpin
structures, did not reveal polymerase pausing within the
repetitive DNAs by the same EM analysis (54), although
Oshima and Wells have used DNA sequencing gels to
demonstrate polymerase pausing by CTG repeats (55).
These results suggest the secondary structure formed
within FRA16B is likely more extensive than a single
hairpin and highly stable. A highly stable replication
fork with exposed single-stranded regions can trigger the
ATR-dependent DNA damage checkpoint pathway,
which in turn inhibits further ﬁring of replication
origins, blocks entry into mitosis and promotes DNA
repair, recombination or apoptosis (56,57). However, a
deﬁciency of proteins in the ATR-dependent cell cycle
checkpoint pathway will dramatically increase fragile site
breakage, as several studies have reported (18,24,25,58).
It is important to note that polymerase stalling at sites of
secondary structure is probably only likely when the
FRA16B sequence is located very close to the origin of
replication, and our results are limited due to the fact that
only one construct was analyzed by DNA sequencing gels,
and contained FRA16B located 30bp from the replication
origin.
This study is the ﬁrst to provide evidence of spontane-
ous replication fork reversal within a fragile site sequence
during DNA synthesis. Based on this information, we
propose a model whereby FRA16B instability primarily
arises from polymerase stalling caused by the formation of
secondary structure at the fragile site region (Figure 4B),
coupled with the failure of the ATR checkpoint pathway.
Other mechanisms contributing to fragile site instability
could be due to replication fork regression (Figure 4C),
the formation of stable DNA secondary structures on
the lagging strand template leading to polymerase
skipping (Figure 4D) or replication restart with secondary
structure formed on the newly synthesized strand
(Figure 4E). These mechanisms may be shared among
other fragile DNA sequences. Overall, our results
provide insight into the mechanism of fragile site instabil-
ity by demonstrating the ability of a fragile DNA to form
a stable secondary structure that aﬀects replication eﬃ-
ciency and instability, and causes polymerase pausing
during DNA synthesis.
Figure 4. Proposed models of FRA16B instability. (A) Replication fork demonstrating DNA polymerase (gray circle) entering the FRA16B sequence
(bold). (B) During FRA16B replication, the polymerase has a high tendency to pause, likely at regions of secondary structure formation.
Consequently, DNA strand breakage, deletions or insertions may arise. (C) FRA16B may promote spontaneous fork reversal, leading to a
four-stranded chickenfoot intermediate. (D) FRA16B may form an extensive secondary structure on a template strand or (E) a newly synthesized
strand, leading to deletions and insertions, respectively.
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